ProfileGDS4718 / 219972_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 61% 71% 41% 57% 61% 68% 50% 52% 57% 65% 58% 62% 68% 67% 66% 70% 70% 61% 43% 47% 54% 61% 56% 59% 74% 61% 64% 59% 64% 64% 67% 56% 61% 69% 68% 68% 49% 51% 71% 60% 65% 71% 74% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.003258
GSM549102patient 115, normal, homogenized [OPG study]6.173961
GSM549104patient 119, normal, homogenized [OPG study]7.0422571
GSM549108patient 138, normal, homogenized [OPG study]5.1003741
GSM549119patient 077, normal, homogenized [OPG study]5.9106357
GSM549133patient 032, cancer, homogenized [OPG study]6.2018861
GSM549139patient 042, cancer, homogenized [OPG study]6.7127968
GSM549099patient 107, normal, homogenized [OPG study]5.5052850
GSM549109patient 139, normal, homogenized [OPG study]5.6308652
GSM549110patient 046, normal, homogenized [OPG study]5.9295757
GSM549114patient 063, normal, homogenized [OPG study]6.4440665
GSM549122patient 082, normal, homogenized [OPG study]5.9888558
GSM549134patient 033, cancer, homogenized [OPG study]6.2544962
GSM549136patient 036, cancer, homogenized [OPG study]6.7495968
GSM549140patient 044, cancer, homogenized [OPG study]6.6172867
GSM549111patient 047, normal, homogenized [OPG study]6.6027466
GSM549113patient 057, normal, homogenized [OPG study]6.8755470
GSM549132patient 031, cancer, homogenized [OPG study]6.9127570
GSM549137patient 038, cancer, homogenized [OPG study]6.2212461
GSM549142patient 047, cancer, homogenized [OPG study]5.2553843
GSM549100patient 110, normal, homogenized [OPG study]5.351747
GSM549107patient 135, normal, homogenized [OPG study]5.704654
GSM549115patient 068, normal, homogenized [OPG study]6.1816961
GSM549116patient 072, normal, homogenized [OPG study]5.8550656
GSM549120patient 078, normal, homogenized [OPG study]6.0697459
GSM549131patient 030, cancer, homogenized [OPG study]7.2996474
GSM549118patient 074, normal, homogenized [OPG study]6.2222861
GSM549129patient 027, cancer, homogenized [OPG study]6.4286964
GSM549123patient 088, normal, homogenized [OPG study]6.0468959
GSM549124patient 006, cancer, homogenized [OPG study]6.4006264
GSM549126patient 015, cancer, homogenized [OPG study]6.401364
GSM549128patient 025, cancer, homogenized [OPG study]6.709267
GSM549103patient 117, normal, homogenized [OPG study]5.8890856
GSM549117patient 073, normal, homogenized [OPG study]6.1293361
GSM549138patient 041, cancer, homogenized [OPG study]6.7996169
GSM549141patient 045, cancer, homogenized [OPG study]6.8149868
GSM549130patient 028, cancer, homogenized [OPG study]6.660268
GSM549101patient 111, normal, homogenized [OPG study]5.5016249
GSM549105patient 128, normal, homogenized [OPG study]5.6120951
GSM549106patient 134, normal, homogenized [OPG study]7.040971
GSM549112patient 048, normal, homogenized [OPG study]6.1090960
GSM549125patient 011, cancer, homogenized [OPG study]6.4878765
GSM549127patient 024, cancer, homogenized [OPG study]7.0823171
GSM549135patient 035, cancer, homogenized [OPG study]7.3646674